rectal cancer
Erbitux meets gold standard in rectal cancer
June 7, 2011Research and Development, Sales and Marketing Erbitux, Merck Serono, rectal cancer
Studies of Merck Serono’s Erbitux in rectal cancer have shown improved overall survival, a gold standard measure in oncology trials. …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
